Porton Biopharma, Limited, Salisbury received a Warning Letter following their most recent audit (View Link).  Porton Biopharma, Limited, Salisbury, was audited from March 7-18, 2016 as a follow-up to an audit conducted January 12-23, 2015 wherein similar findings were observed.  The repetition of these findings were observed to be so substantial that the FDA will … [Read more...]